We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
(+8.9%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$127M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$126M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$122M |
| 4 |
SkinHealth Systems
SKIN
|
+$90.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$210M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$187M |
| 3 |
XYZ
Block Inc
XYZ
|
+$111M |
| 4 |
Danaher
DHR
|
+$109M |
| 5 |
Monster Beverage
MNST
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Financials | 16.56% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
T. Rowe Price
TROW
$25B
| $51.8M | 0.22% |
263,453
+167,989
| +176% | +$35.4M |
|
77
Scotiabank
BNS
$106B
| $51.5M | 0.21% |
836,796
+209,781
| +33% | +$13.1M |
|
78
Academy Sports + Outdoors
ASO
$2.89B
| $51.5M | 0.21% |
1,286,524
+1,215,891
| +1,721% | +$48.5M |
|
79
MGM Resorts International
MGM
$11.7B
| $51M | 0.21% |
1,180,912
+897,202
| +316% | +$36.6M |
|
|
ASZ
80
DELISTED
Austerlitz Acquisition Corporation II
ASZ
| $50.2M | 0.21% |
5,144,032
+2,340,676
| +83% | +$22.8M |
|
81
Roku
ROKU
$21.1B
| $49.9M | 0.21% |
159,225
-12,032
| -7% | -$4.53M |
|
82
Franklin Resources
BEN
$16.9B
| $49.9M | 0.21% |
1,678,213
+1,480,385
| +748% | +$46.2M |
|
83
Starbucks
SBUX
$118B
| $49.8M | 0.21% |
451,230
+127,067
| +39% | +$14.9M |
|
84
PUT
Meta Platforms (Facebook)
META
$1.51T
| $49.7M | 0.21% |
146,300
+47,400
| +48% | +$17.1M |
|
85
PTC
PTC
$13.7B
| $49.3M | 0.2% |
+411,570
| New | +$54.9M |
|
86
CALL
NVIDIA
NVDA
$5.01T
| $47.9M | 0.2% |
2,314,000
+1,998,000
| +632% | +$41.5M |
|
|
PSTH
87
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $47.6M | 0.2% |
+2,417,478
| New | +$49M |
|
88
Linde
LIN
$237B
| $47.4M | 0.2% |
160,166
+28,532
| +22% | +$8.67M |
|
89
EPAM Systems
EPAM
$4.69B
| $45.9M | 0.19% |
80,539
+44,295
| +122% | +$26.1M |
|
90
Global Payments
GPN
$22.1B
| $45.9M | 0.19% |
290,988
+253,107
| +668% | +$44M |
|
91
ZIM Integrated Shipping Services
ZIM
$3B
| $45M | 0.19% |
888,486
+335,800
| +61% | +$15.7M |
|
|
JWSM
92
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
| $45M | 0.19% |
4,613,815
+3,426,781
| +289% | +$33.4M |
|
93
Toronto Dominion Bank
TD
$198B
| $44.5M | 0.18% |
672,178
+389,673
| +138% | +$26M |
|
94
Sabre
SABR
$656M
| $44.1M | 0.18% |
3,728,445
-615,099
| -14% | -$6.97M |
|
95
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $44M | 0.18% |
503,200
-515,300
| -51% | -$45.2M |
|
96
PUT
Amazon
AMZN
$2.5T
| $44M | 0.18% |
268,000
+228,000
| +570% | +$39.3M |
|
97
Visa
V
$677B
| $43.9M | 0.18% |
197,155
-89,869
| -31% | -$21.1M |
|
98
Royalty Pharma
RPRX
$26.1B
| $43.4M | 0.18% |
+1,201,980
| New | +$46.7M |
|
99
10x Genomics
TXG
$5.87B
| $43.3M | 0.18% |
+297,343
| New | +$51M |
|
100
Burlington
BURL
$22B
| $43.2M | 0.18% |
152,486
+114,355
| +300% | +$36.6M |
|
Similar funds
Marshall Wace's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.
- Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
- Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
- Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
- Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
- Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
- Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
- Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.
Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.